The expanding genetic overlap between multiple sclerosis and type I diabetes
David R. Booth(Hammersmith Hospital), Jonathan L. Haines(Vanderbilt University), Åslaug Rudjord Lorentzen, An Goris(University of Cambridge), Tomas Olsson(Karolinska University Hospital), Amie Baker(University of Oxford), Rita Dobosi(KU Leuven), Tania Mihalova(Keele University), Maria Ban(University of Cambridge), Gillian Ingram(Cardiff and Vale University Health Board), Clive Hawkins(University of Liverpool), Jacob L. McCauley(University of Cambridge), Philip L. De Jager(Broad Institute), Jan Hillert(Karolinska University Hospital), Anne Spurkland(University of Oslo), David Sexton(Vanderbilt University), Hanne F. Harbo, Margaret A. Pericak‐Vance(University of Miami), Robert Heard, Ingrid Kockum(Karolinska Institutet), Stephen Sawcer(University of Cambridge), Jenny Link(Karolinska Institutet), Alastair Compston(University of Cambridge), Lisa F. Barcellos(University of California, San Francisco), Elisabeth Gulowsen Celius(Oslo University Hospital), Jorge R. Oksenberg(University of California, San Francisco), Neil P. Robertson(Cardiff University), Bénédicte Dubois(University of California, San Francisco), Adrian J. Ivinson, Graeme J. Stewart, Richard C. Strange(Royal Stoke University Hospital), Stephen L. Hauser(University of California, San Francisco), David A. Hafler(Yale University)
Cited by 170
Related Papers
Finding the missing heritability of complex diseases
|Nature|2009|8.5k
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
|Nature|2011|2.8k
Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration
|Science|2005|2.4k
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
|Nature Genetics|2011|2k
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
|New England Journal of Medicine|2016|2k